A detailed history of Tokio Marine Asset Management CO LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Tokio Marine Asset Management CO LTD holds 1,978 shares of CRL stock, worth $371,349. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,978
Previous 1,954 1.23%
Holding current value
$371,349
Previous $403,000 3.47%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$187.96 - $245.29 $4,511 - $5,886
24 Added 1.23%
1,978 $389,000
Q2 2024

Jul 26, 2024

SELL
$206.39 - $268.73 $6,604 - $8,599
-32 Reduced 1.61%
1,954 $403,000
Q1 2024

May 02, 2024

BUY
$203.52 - $273.43 $77,948 - $104,723
383 Added 23.89%
1,986 $538,000
Q4 2023

Feb 02, 2024

BUY
$164.52 - $238.84 $21,881 - $31,765
133 Added 9.05%
1,603 $378,000
Q3 2023

Nov 02, 2023

BUY
$194.44 - $217.61 $24,888 - $27,854
128 Added 9.54%
1,470 $288,000
Q2 2023

Jul 28, 2023

BUY
$183.71 - $210.25 $6,980 - $7,989
38 Added 2.91%
1,342 $282,000
Q1 2023

May 11, 2023

BUY
$191.89 - $259.92 $22,834 - $30,930
119 Added 10.04%
1,304 $263,000
Q4 2022

Jan 26, 2023

BUY
$197.11 - $250.07 $26,609 - $33,759
135 Added 12.86%
1,185 $0
Q3 2022

Nov 10, 2022

BUY
$182.44 - $250.54 $10,581 - $14,531
58 Added 5.85%
1,050 $207,000
Q2 2022

Aug 09, 2022

BUY
$204.13 - $302.4 $48,787 - $72,273
239 Added 31.74%
992 $212,000
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $17,374 - $24,623
68 Added 9.93%
753 $214,000
Q4 2021

Jan 26, 2022

BUY
$351.38 - $448.68 $27,407 - $34,997
78 Added 12.85%
685 $258,000
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $226,192 - $278,188
607 New
607 $250,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.55B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Tokio Marine Asset Management CO LTD Portfolio

Follow Tokio Marine Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.